Bloom syndrome: symptoms, causes, diagnosis and care
Table of Contents
Key takeaways
- Bloom syndrome is a rare inherited condition caused by changes in the BLM gene, affecting DNA repair and chromosome stability.
- Features can include short stature from birth, sun-sensitive facial rash, recurrent infections, fertility issues and a substantially increased lifetime cancer risk.
- Diagnosis usually involves clinical assessment and genetic testing, with genetic counselling for the person and family.
- Care focuses on cancer surveillance, infection management, sun protection, growth and nutrition support, fertility counselling and coordinated specialist follow-up.
Overview
Bloom syndrome is a rare genetic condition that affects how cells repair and maintain DNA. It is sometimes called Bloom-Torre-Machacek syndrome. People with Bloom syndrome are usually much smaller than average from birth, are sensitive to sunlight and have a high risk of developing cancer earlier in life than the general population.
The condition is lifelong and needs specialist care. There is no simple home remedy that can correct the underlying DNA repair problem. Management is built around prevention of avoidable harm, early recognition of complications, tailored cancer surveillance, infection care, nutrition support and family genetic counselling.
Because Bloom syndrome is rare, many families will be cared for by a combination of local clinicians and specialist genetics, immunology, dermatology, oncology, endocrinology and fertility teams. Care plans should be personalised and kept up to date as the person moves from childhood into adult services.
The condition affects several body systems, so care is usually proactive rather than symptom-only. Families may need written plans for sun exposure, infection response, cancer warning symptoms, school support, growth monitoring and who to contact if new symptoms appear between scheduled reviews.
Symptoms and complications
Common features include low birth weight, short stature, a narrow face, sun-sensitive rash across the cheeks and nose, and areas of lighter or darker skin. Small widened blood vessels, called telangiectases, can appear in the rash or eyes. The rash is often triggered or worsened by ultraviolet light.
Some people have recurrent infections, especially of the ears, upper respiratory tract and lungs, because of immune system differences. Diabetes, chronic lung disease, feeding difficulties, reflux and learning differences may also occur. Men with Bloom syndrome are usually infertile because they do not produce sperm, while women may have reduced fertility and earlier menopause.
The most serious complication is cancer risk. Cancers can occur at younger ages, and more than one cancer type may develop over a lifetime. This risk is linked to genomic instability, where DNA damage and chromosome changes are more likely to accumulate.
Causes and inheritance
Bloom syndrome is caused by pathogenic variants in both copies of the BLM gene. The BLM gene helps make a RecQ helicase protein involved in unwinding DNA during copying and repair. When this system does not work properly, chromosomes are more prone to breaks, rearrangements and excess sister chromatid exchange.
The inheritance pattern is autosomal recessive. This means a child usually develops Bloom syndrome when they inherit one altered BLM gene copy from each carrier parent. Carrier parents typically do not have symptoms. If both parents are carriers, genetic counselling can explain recurrence risks for future pregnancies.
The condition has been reported in people from different backgrounds, with a higher carrier frequency described in people of Ashkenazi Jewish ancestry. Ancestry can guide carrier testing conversations, but it should not be used to exclude the diagnosis if clinical features fit.
Diagnosis and genetic testing
Diagnosis may be suspected from growth pattern, sun-sensitive rash, characteristic facial features, infections, family history or early cancer. Genetic testing can look for BLM gene variants. In some settings, chromosome studies showing increased sister chromatid exchange may also support the diagnosis.
In the UK, genomic testing is usually arranged through NHS clinical genetics or specialist services when the result could guide diagnosis, surveillance, family testing or reproductive choices. Testing should include pre-test counselling so families understand possible results, limitations and implications for relatives.
Once diagnosed, baseline assessment may include growth and nutrition review, skin assessment, immune function, glucose monitoring, lung assessment, cancer risk planning and review of development, education and psychosocial needs.
A confirmed result can also prevent repeated uncertainty. For example, short stature may otherwise lead to many separate investigations, while recurrent infections or sun-sensitive rash may be treated as isolated problems. A genetic diagnosis helps clinicians connect these features and plan surveillance around the known cancer-predisposition risk.
Treatment and long-term management
Management does not reverse the genetic cause, so care aims to reduce complications and detect problems early. Sun protection is important: shade, protective clothing, broad-spectrum sunscreen and avoiding unnecessary ultraviolet exposure can reduce rash flares and skin damage.
Cancer surveillance should be led by specialists familiar with Bloom syndrome because standard population screening may not be enough and some radiation-based tests may need careful consideration. Families should have clear advice about symptoms that need prompt review, such as unexplained weight loss, persistent lumps, unusual bleeding, ongoing fever, night sweats or persistent pain.
Infections should be assessed and treated appropriately. Some people may need immunology review, vaccination planning or extra support for recurrent respiratory infections. Nutrition and growth support can help with feeding problems and energy needs, while endocrine review may be needed for diabetes or puberty concerns.
Medication and imaging decisions may need extra care because DNA repair disorders can change risk-benefit discussions. This does not mean tests or treatments should be avoided when needed; it means the team should choose the safest effective approach and document the reason. Oncology care, if cancer develops, should involve clinicians who understand inherited chromosome instability syndromes.
Family planning and support
Genetic counselling can help relatives understand carrier testing, reproductive options and family communication. Options may include carrier testing for relatives, testing in pregnancy, or pre-implantation genetic testing where available and appropriate.
Living with a rare cancer-predisposition syndrome can affect mental wellbeing, school, work, insurance questions and family planning. Psychological support, rare disease charities and coordinated care can make practical decision-making easier.
When to seek medical advice
Seek prompt medical advice for fever, recurrent infections, breathing difficulty, unexplained lumps, persistent pain, unusual bleeding, blood in stool or urine, weight loss, night sweats, severe sun reaction, new neurological symptoms or any symptom that is unusual for the person. Use NHS 111 for urgent advice or call 999 in a life-threatening emergency.
Sources
- MedlinePlus Genetics – Bloom syndrome: https://medlineplus.gov/genetics/condition/bloom-syndrome/
Relevance: Provides authoritative genetic overview, symptoms, inheritance and BLM gene mechanism for Bloom syndrome. - NHS – Genetic and genomic testing: https://www.nhs.uk/conditions/genetic-and-genomic-testing/
Relevance: Supports UK-facing explanation of genomic testing and counselling considerations. - PubMed – Bloom syndrome clinical review: https://pubmed.ncbi.nlm.nih.gov/20301572/
Relevance: Supports clinical detail on rare inherited Bloom syndrome, cancer predisposition and specialist management themes.
Disclaimer
Educational only. Results vary. Not a cure.
